UTHR
USDUnited Therapeutics Corporation Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$432.750
उच्च
$440.000
कम
$430.020
मात्रा
0.35M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
18.8B
उद्योग
Drug Manufacturers - Specialty & Generic
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
0.79M
एक्सचेंज
NMS
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
United Therapeutics Corporation to Present at Upcoming Investor Conferences
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that company executives will provide an overview and update on the company during fireside chat sessions at two upcoming
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
Ongoing EXPAND Study is the First Clinical Trial to Evaluate Xenotransplantation in End-Stage Renal Disease United Therapeutics Corporation (Nasdaq: UTHR) today announced the first clinical xenotransplantation in its
HC Wainwright & Co. Maintains Buy on United Therapeutics, Raises Price Target to $525
HC Wainwright & Co. analyst Andrew S. Fein maintains United Therapeutics with a Buy and raises the price target from $500 to $525.
RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $587
RBC Capital analyst Lisa Walter maintains United Therapeutics with a Outperform and raises the price target from $569 to $587.
Wells Fargo Maintains Equal-Weight on United Therapeutics, Raises Price Target to $423
Wells Fargo analyst Benjamin Burnett maintains United Therapeutics with a Equal-Weight and raises the price target from $414 to $423.
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced record financial results for the quarter ended September 30, 2025, driven by continued year-over-year revenue growth in key
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. A press release detailing the quarterly
संबंधित स्टॉक
QRTEP
Qurate Retail Inc. 8.0% Fixed Rate Cumulative Redeemable Preferred Stock
BHE
Benchmark Electronics Inc.
NMRA
Neumora Therapeutics Inc.
MUC
Blackrock MuniHoldings California Quality Fund Inc.
DRI
Darden Restaurants Inc.
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।